{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "58-year-old Chinese male presented for a physical examination on April 20, 2020. Asymptomatic, with no cough, sputum, hemoptysis, chest pain, or dyspnea. No history of diabetes, hypertension, or family history of cancer. Smoking history of over 7 years, with an average of 20\u201340 cigarettes per day, and had abstained from smoking for nearly 30 years.",
        "clinical_data": {
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "History of over 7 years, with an average of 20\u201340 cigarettes per day, and had abstained from smoking for nearly 30 years."
            }
          ],
          "HPI": [
            {
              "summary": "Asymptomatic, with no cough, sputum, hemoptysis, chest pain, or dyspnea.",
              "onset": "April 20, 2020"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Chest CT revealed a 4.0 cm x 3.4 cm mass in the inferior lobe of the right lung, with swollen and fused lymph nodes in the hilum and mediastinum.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "4.0 cm x 3.4 cm mass in the inferior lobe of the right lung, with swollen and fused lymph nodes in the hilum and mediastinum."
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "CT-guided lung biopsy revealed lung adenocarcinoma. Immunohistochemical staining positive for Napsin A and TTF1.",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT guided lung biopsy",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "lung adenocarcinoma",
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0242397",
              "label": "Adenocarcinoma of lung",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Diagnosis of stage IIIA (T2aN2M0) lung adenocarcinoma confirmed on May 2, 2020.",
        "timestamp": "2020-05-02",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Lung cancer, unspecified",
              "status": "active",
              "onset_date": "2020-05-02"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "NGS of tumor tissue from lung puncture identified ELMOD3-ALK (E8: A20) fusion (41.23% abundance) and EML4-ALK (E13: A20) double-ALK fusion (68.21% abundance). ELMOD3-ALK fusion involved exon 8 of ELMOD3 and exon 20 of ALK. ALK fusion confirmed by IHC staining (Ventana D5F3 clone).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "Puncture",
              "body_part": "Lung",
              "modality": "other",
              "finding": "Tumor tissue",
              "date": null
            }
          ],
          "labs": [
            {
              "test": "ELMOD3-ALK (E8: A20) fusion",
              "value": "41.23%",
              "unit": "% abundance",
              "flag": "abnormal"
            },
            {
              "test": "EML4-ALK (E13: A20) double-ALK fusion",
              "value": "68.21%",
              "unit": "% abundance",
              "flag": "abnormal"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Initiated alectinib therapy at 600 mg twice daily on May 20, 2020, following MDT discussion for potentially resectable NSCLC with ALK rearrangement.",
        "timestamp": "2020-05-20",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1698449",
              "dosage": "600 mg",
              "frequency": "twice daily",
              "modality": "oral",
              "start_date": "2020-05-20",
              "end_date": null,
              "indication": "C0027423"
            }
          ],
          "diagnoses": [
            {
              "code": "C0027423",
              "label": "Non-Small Cell Lung Carcinoma",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Chest CT scan after 4 months of alectinib therapy showed shrinkage of the primary tumor and a 1.1 cm x 0.6 cm nodule in the inferior lobe of the right lung. No lymph node enlargement. CEA",
        "clinical_data": {
          "imaging": [
            {
              "type": "CT scan of chest",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Shrinkage of the primary tumor and a 1.1 cm x 0.6 cm nodule in the inferior lobe of the right lung. No lymph node enlargement.",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "alectinib",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient underwent chest CT."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "CT-guided lung biopsy performed."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Diagnosis confirmed."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "NGS of tumor tissue performed."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of alectinib therapy following MDT discussion.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1698449"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2020-05-20"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Chest CT scan performed after 4 months of alectinib therapy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "imaging"
        }
      }
    }
  ]
}